Asia Horizon is focused on the emerging hemp-derived cannabinoid industry in China. It is the first and only North American firm to secure a license to extract cannabinoids from hemp grown in China. Early mover establishing large-scale, low-cost production for the global supply chain. China is the Global Leader in Active Pharmaceutical Ingredients (API) and we believe potentially that the global cannabinoid supply chain will mirror the global pharmaceutical & nutraceutical supply chains.
February 2016January 2017August 2017August 2018March 2017April 2018January 2020December 2019May 2019January 2019August 2019April 2019January 2020April 2019Ocotober 2019May 2018December 2018August 2015December 2018January 2019October 2015December 2018December 2018December 2016August 2018November 2015August 2019June 2019April 2019September 2015September 2015